Critical Care

official impact factor 4.60

Highly Access Email this article to a friend

Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?

Jan O Friedrich*, Neill KJ Adhikari and Maureen O Meade

Critical Care 2006, 10:145 doi:10.1186/cc4947

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.